The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)

Publication | Closed Access

DOI

Citations

References

2019

Year

Ryusuke Murakami, Noriomi Matsumura, Hirofumi Michimae, Hiroshi Tanabe, Mayu Yunokawa, Haruko Iwase, M Sasagawa, Toshiaki Nakamura, Osamu Tokuyama, Masashi Takano,

Gynecologic Oncology

Mesenchymal Transition SubtypeMalignant DiseaseDense Taxane ChemotherapyMedicineGynecologyCarboplatin ChemotherapyCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer